DK425885A - Antistof, fremgangsmaade til fremstilling heraf samt anvendelse vedpaavisning af oncogene produkter - Google Patents

Antistof, fremgangsmaade til fremstilling heraf samt anvendelse vedpaavisning af oncogene produkter Download PDF

Info

Publication number
DK425885A
DK425885A DK425885A DK425885A DK425885A DK 425885 A DK425885 A DK 425885A DK 425885 A DK425885 A DK 425885A DK 425885 A DK425885 A DK 425885A DK 425885 A DK425885 A DK 425885A
Authority
DK
Denmark
Prior art keywords
antibody
preparing
determination
procedure
oncogen
Prior art date
Application number
DK425885A
Other languages
Danish (da)
English (en)
Other versions
DK425885D0 (da
Inventor
Francis P Mccormick
Robin Clark
Danute E Nitecki
Gail L Wong
Norman Arnheim
Original Assignee
Cetus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cetus Corp filed Critical Cetus Corp
Publication of DK425885D0 publication Critical patent/DK425885D0/da
Publication of DK425885A publication Critical patent/DK425885A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82Translation products from oncogenes
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/81Packaged device or kit
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/961Chemistry: molecular biology and microbiology including a step of forming, releasing, or exposing the antigen or forming the hapten-immunogenic carrier complex or the antigen per se
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/807Apparatus included in process claim, e.g. physical support structures
    • Y10S436/808Automated or kit
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/811Test for named disease, body condition or organ function
    • Y10S436/813Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DK425885A 1984-09-19 1985-09-19 Antistof, fremgangsmaade til fremstilling heraf samt anvendelse vedpaavisning af oncogene produkter DK425885A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US65275284A 1984-09-19 1984-09-19
US06/661,909 US4798787A (en) 1984-09-19 1984-10-17 Peptide antibodies and their use in detecting oncogene products

Publications (2)

Publication Number Publication Date
DK425885D0 DK425885D0 (da) 1985-09-19
DK425885A true DK425885A (da) 1986-03-20

Family

ID=27096357

Family Applications (1)

Application Number Title Priority Date Filing Date
DK425885A DK425885A (da) 1984-09-19 1985-09-19 Antistof, fremgangsmaade til fremstilling heraf samt anvendelse vedpaavisning af oncogene produkter

Country Status (8)

Country Link
US (1) US4798787A (de)
EP (1) EP0175360A3 (de)
AU (1) AU591461B2 (de)
CA (1) CA1265649A (de)
DE (1) DE175360T1 (de)
DK (1) DK425885A (de)
IL (1) IL76387A (de)
NZ (1) NZ213535A (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3346953A1 (de) * 1983-12-24 1985-08-14 Organogen Medizinisch-Molekularbiologische Forschungsgesellschaft mbH, 6900 Heidelberg Cardiodilatin, ein neues peptidhormon und verfahren zu seiner herstellung
US4762706A (en) * 1984-10-17 1988-08-09 Cetus Corporation Peptide antibodies and their use in detecting oncogene products
US5084380A (en) * 1985-01-29 1992-01-28 Applied Biotechnology Monoclonal antibodies reactive with activated and oncogenic ras p21 proteins
CA1296660C (en) * 1985-01-29 1992-03-03 Walter P. Carney Monoclonal antibody against a ras oncogene p21 related dodecapeptide
US5443956A (en) * 1985-01-29 1995-08-22 Oncogene Science, Inc. Detection, quantitation and classification of RAS proteins in body fluids and tissues
US6200764B1 (en) 1985-01-29 2001-03-13 Bayer Corporation Detection, quantitation and classification of ras proteins in body fluids and tissues
US4898932A (en) * 1985-01-29 1990-02-06 E. I. Du Pont De Nemours And Company Monoclonal antibodies reactive with activated and oncogenic ras p21 proteins
EP0203587A3 (de) * 1985-05-30 1989-08-09 F. Hoffmann-La Roche Ag Ras-Oncogene-Peptide und Antikörper
US6083709A (en) * 1985-08-21 2000-07-04 Osi Pharmaceuticals, Inc. Immunoassay for detection of mutant P53 polypeptide in serum
IL79755A0 (en) * 1985-08-21 1986-11-30 Oncogene Science Inc Immunoassay for detection of ras encoded protein
US5015568A (en) * 1986-07-09 1991-05-14 The Wistar Institute Diagnostic methods for detecting lymphomas in humans
JPS6374492A (ja) * 1986-09-18 1988-04-04 Hiroshi Shiyuku モノクロ−ナル抗体
US4968603A (en) * 1986-12-31 1990-11-06 The Regents Of The University Of California Determination of status in neoplastic disease
CA1339069C (en) * 1987-11-09 1997-07-29 Henry Lee Niman Polypeptide-induced monoclonal receptors to protein ligand
US5112737A (en) * 1988-02-22 1992-05-12 Applied Biotechnology, Inc. Monoclonal antibodies against activated ras proteins with amino acid mutations at position 13 of the protein
EP0370012A1 (de) * 1988-03-08 1990-05-30 E.I. Du Pont De Nemours And Company Monoklonale antikörper, empfänglich für aktivierte und onkogenische ras p21-proteine
ATE154134T1 (de) * 1988-04-22 1997-06-15 Oncogene Science Inc Nachweis, quantifizierung und klassifizierung von ras-proteinen in körperflüssigkeiten und geweben
FI910084A0 (fi) * 1988-07-08 1991-01-07 Smithkline Beckman Corp Retrovirala proteaser bindande peptider.
WO1990001701A1 (en) * 1988-08-12 1990-02-22 Progenx, Inc. Polypeptide-induced monoclonal receptors to protein ligands
FR2660757B1 (fr) * 1990-04-06 1994-05-27 Immunotech Sa Procede d'identification ou de dosage de proteines et applications.
WO1992000311A1 (en) * 1990-06-27 1992-01-09 Princeton University Probes for detecting mutant p53
US5620848A (en) * 1990-06-27 1997-04-15 Trustees Of Princeton University Methods for detecting mutant p53
US5650489A (en) * 1990-07-02 1997-07-22 The Arizona Board Of Regents Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof
AU1370592A (en) * 1991-02-01 1992-09-07 Oncogene Science, Inc. Immunoassay for detection of mutant p53 polypeptide in biological fluids
US6150398A (en) * 1991-05-08 2000-11-21 The United States Of America As Represented By The Department Of Health And Human Services Methods for the treatment of cancer
US6160106A (en) * 1993-10-12 2000-12-12 Yeda Research & Development Co., Ltd. Tumor suppressor genes, proteins encoded thereby and use of said genes and proteins
IL107250A (en) * 1993-10-12 2001-08-08 Yeda Res & Dev Dna molecules involved in programmed cell death, proteins encoded thereby and methods and compositions using said dna molecules and proteins
US20020006629A1 (en) * 2000-02-29 2002-01-17 Danishefsky Samuel J. Affinity matrix bearing tumor-associated carbohydrate-or glycopeptide-based antigens and uses thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4535058A (en) * 1982-10-01 1985-08-13 Massachusetts Institute Of Technology Characterization of oncogenes and assays based thereon
US4699877A (en) * 1982-11-04 1987-10-13 The Regents Of The University Of California Methods and compositions for detecting human tumors
IE56509B1 (en) * 1982-11-04 1991-08-28 Univ California Methods for oncogenic detection
ZA84617B (en) * 1983-02-14 1984-09-26 Arup Sen Synthetic polypeptides from viryl oncogenes
NZ207394A (en) * 1983-03-08 1987-03-06 Commw Serum Lab Commission Detecting or determining sequence of amino acids
CA1219232A (en) * 1983-08-17 1987-03-17 Richard A. Lerner Polypeptide-induced monoclonal receptors to protein ligands
US4658022A (en) * 1985-08-08 1987-04-14 Molecular Diagnostics, Inc. Binding of antibody reagents to denatured protein analytes

Also Published As

Publication number Publication date
IL76387A (en) 1991-08-16
IL76387A0 (en) 1986-01-31
EP0175360A2 (de) 1986-03-26
DK425885D0 (da) 1985-09-19
US4798787A (en) 1989-01-17
AU4756985A (en) 1986-03-27
NZ213535A (en) 1991-05-28
AU591461B2 (en) 1989-12-07
DE175360T1 (de) 1986-09-25
EP0175360A3 (de) 1988-03-30
CA1265649A (en) 1990-02-06

Similar Documents

Publication Publication Date Title
DK425885D0 (da) Antistof, fremgangsmaade til fremstilling heraf samt anvendelse vedpaavisning af oncogene produkter
DK499783D0 (da) Vaeskeopsugende baneformet emne samt fremgangsmade til fremstilling af dette
DK165606C (da) Apparat til identifikation af moenter eller lignende
DK74087D0 (da) Indolizinderivater og fremgangsmaade til fremstilling deraf samt midler indeholdende derivaterne
DK380986A (da) Fremgangsmaade til fremstilling af piperidinderivater
DK477686D0 (da) Heteropolysaccharid, fremgangsmaade til fremstilling deraf og anvendelse deraf i et kompleks samt fremgangsmaade til fremstilling af et saadant kompleks
DK497682A (da) Fremgangsmaade til fremstilling af 7-oxabicycloheptan- og 7-oxabicycloheptenprostaglandinanaloge
DK261086D0 (da) Katalysator til katalytisk krakning og fremgangsmaade til fremstilling af samme samt anvendelse heraf
DK382785A (da) Alfa-(o-chlorphenyl)-aminomethylen-beta-formylaminopropionitril, fremgangsmaade til fremstilling af dette samt anvendelse af dette til fremstilling af 2-methyl-4-amino-5-formylaminomethyl-pyrimidin
DK375987A (da) Fremgangsmaade til fremstilling af cycloalkyl-sub-stituerede 4-pyridyl derivater
DK62986A (da) Cigaretfilter samt fremgangsmaade til fremstilling af dette
DK515685A (da) Tobaksfilter samt fremgangsmaade til fremstilling af dette
DK448887A (da) Hidtil ukendt amylaseenzym og fremgangsmaade til fremstilling af samme
DK156085D0 (da) Fremgangsmaade til fremstilling af acetoxyazetidinoner
DK549087A (da) Gangliosidbeslaegtede forbindelser og fremgangsmaade til fremstilling af samme
DK115685D0 (da) Prespap samt fremgangsmaade til fremstilling deraf
DK28788A (da) Fremgangsmaade til fremstilling af alkansulfonamider
DK593985A (da) Olieadjuveret vaccine samt fremgangsmaade til fremstilling deraf
DK361387D0 (da) Fremgangsmaade til fremstilling af piperidinopyrimidin
DK554885D0 (da) Krystallinsk zirconiumphosphat, samt fremgangsmaade til fremstilling af dette
DK292088A (da) Rense- og skuregenstand samt fremgangsmaade til fremstilling af samme
DK110582A (da) 2-benzoylamino-substituerede benzylaminderivater samt fremgangsmaade til fremstilling af samme
DK350288A (da) Fremgangsmaade til fremstilling af n-epoxypropyllactamer
DK464387A (da) Fastgoerelsesorgan og fremgangsmaade til fremstilling af dette
DK987A (da) Fremgangsmaade til fremstilling af tetrachlorpyri- din

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment